Title of Invention

AN INTERMEDIATE COMPOUND FOR THE PREPARATION OF ACID ESTERS AND DERIVATIVES

Abstract The invention relates to a novel process for the preparation of certain cyclopropyl carboxylic acid esters and other cyclopropyl carboxylic acid derivatives; a novel process for the preparation of dimethylsulfoxonium methylide and dimethylsulfonium methylide; to the use of certain cyclopropyl carboxylic acid esters in a process for the preparation of intermediates that can be used in the synthesis of pharmaceutically active entities; and to certain intermediates provided by these processes.
Full Text FORM 2
THE PATENTS ACT 1970
[39 OF 1970]
&
THE PATENTS RULES, 2003
COMPLETE SPECIFICATION
[See Section 10; rule 13]
"AN INTERMEDIATE COMPOUND FOR THE PREPARATION OF ACID ESTERS AND DERIVATIVES"
ASTRAZENECA AB, a Swedish company, of S-151 85 Sodertalje, Sweden,
The following specification particularly describes the invention and the manner in which it is to be performed:

WO 01/92200

PCT/SE01/0124

PROCESS FOR THE PREPARATION OF CYCLOPROPYL CARBOXYLIC ACID ESTERS AND DERIVATIVES
FIELD OF THE INVENTION
The present invention relates to a novel process for the preparation of certain cyclopropyl carboxylic acid esters and other cyclopropyl carbox3rlic acid derivatives; a novel process for the preparation of dimemylsulfoxoniurn methylide and dirnethylsulfonium methylide; to the use .of certain cyclopropyl carboxylic acid esters in a process for the preparation of intermediates that can be used in the synthesis of pharmaceutically active entities; and to certain intermediates
provided by these processes.
10
DESCRIPTION OF THE INVENTION
In a first aspect the invention therefore provides a process for the preparation of a
compound of formula (I):
O



wherein: is
R is phenyl substituted with one or more halogen;
Y is OR-1 . where R1 is a straight chain alkyl, branched alkyl, cycloalkyl, or a substituted
bicycloheptyl group (eg bornyl),
which comprises contacting a compound of formula (TJT): '

20

0
II • R-CH=CH- C — Y
(IT)
where R and Y are as defined above, with dimethylsulfoxonium methylide in the presence of a solvent

WO 01792200

PCT/SE01/0I240

2
Suitably the solvent is a polar solvent, preferably dimethyl sulfoxide. Suitably, the reaction is carried out at -I0°C - 90°C, preferably 25°C.
The dimethylsulfoxonium methylide can be prepared by reacting a trimethylsulfoxonium
5 salt with a solid strong base, preferably in solid form, in dimethyl sulfoxide at ambient or an elevated temperature. Suitably, the base is a metal hydroxide, eg NaOH, LiOH, or alkali metal hydride, eg NaH. Preferably the base is sodium hydroxide.
Preferably, trimethylsulfoxonium iodide is stirred with sodium hydroxide powder in
10 dimethyl sulfoxide(in the absence of a phase transfer catalyst), optionally under nitrogen,
at 20-25°C for 90 minutes. Alternatively, the dimethylsulfoxonium methylide can be prepared from a trimethylsulfoxonium salt (preferably iodide or chloride) using sodium hydroxide in dimethyl sulfoxide with a phase transfer catalyst, for example tetrabutyl-n-ammonium bromide, or with other strong bases, such as. alkali metal hydrides, in dimethyl .
15 sulfoxide.
A compound of formula (II) can be prepared by reacting a compound of formula (HI):
0
II R-CH=CH-C—OH
m

where R is as defined above, with a suitable chlorinating agent in the presence of an inert
20 solvent and an-optional catalyst at at a temperature of 0=2 00 ˚C Preferably Y is OR ,the chlorinating agent is thionyl chloride, the inert solvent is toluene, and the catalyst, is-pyridine. Suitably the reaction temperature is 70°C. The. resulting acid chloride is then reacted with YH or Y~, (where Y" is an anionic species of Y), Y is as defined above, optionally at an elevated temperature, such as 100°C.
25
A compound of formula (III) can be prepared using standard chemistry, for example by contacting a compound of formula (IV):

WO 01/92200

PCT/SE01/01240

3
0
R—C— H (IV)
where R is as defined above, with, malonic acid in the presence of pyridine and piperidine at an elevated temperature, preferably 50-90°C.
A compound of formula (I) can be hydrolysed using basic hydrolysis to yield a compound of formula (V):
O
A "
R—*-* C —OH

where R is as defined above. For example, ester groups are preferably removed by' basic
10 hydrolysis using an alkali metal hydroxide, such as sodium hydroxide or lithium hydroxide, or quaternary ammonium hydroxide in a solvent, such as water, an aqueous alcohol or aqueous tetrahydrofuran, at a temperature from 10 - 100DC. Most preferably the base is sodium hydroxide, the solvent is ethanol, and the reaction temperature is 50°C.
15 A compound of formula (V) can be used to generate a compound of formula (VI):
O
. A' f~ "'
R—*—*—c—a (vr>

where R is as defined above, by reaction with thionyl chloride or another suitable chlorinating agent in the presence of toluene, or another suitable solvent, and an optional catalyst, preferably pyridine, at 0-200°C. Preferably the temperature is to 65-70°C.
A compound of formula (VI) can be used in the synthesis of a compound of formula (VII):

WO 01/92200 PCT/SE01/01240
O
R—^ C—N3
(VH)
where R is as defined above, by reaction with an alkali metal azide (preferably sodium
azide) in the presence of a phase transfer catalyst (preferably terra-n-butylammonium
5 bromide), aqueous potassium carbonate and an inert solvent (preferably toluene).
Preferably the reaction temperature-0-10˚C
A compound of formula (VII) can be used in the synthesis of a compound of formula (VIII): .
10

A
(vm)
R
where R is as defined above, by rearrangement in toluene at temperatures between 0°C and 200°C, preferably at a reaction temperature of 90-100°C, after which the isocyanate intermediate is reached with hydrochloric acid at elevated temperature, preferable 85
15 90˚C

An unprotonated parent amine (free base) of formula(IX)
R—^ NH2
(IX)
20 where R is as defined above, can be liberated by adjusting the pH of an aqueous solution of the salt of a compound of formula (VHI) to 10 01 more. This can then be converted to other salts of organic acids or inorganic acids, preferably mandelic acid. The R-(-)-mandelic acid

WO 01/92200

PCT/SE01/01240

5
salt of a compound of formula (IX) can be generated by addition of R-(-)-mandelic acid at ambient or an elevated temperature to a solution of a compound of formula (TX) in a solvent, preferably ethyl acetate. Preferably the temperature is 20° C.
5 Suitably R is phenyl optionally substituted by one or more halogen atoms. Preferably, R is phenyl substituted by one or more fluorine atoms. More preferably R is 4-fluorophenyl or 3,4-difluorophenyl.
Preferably Y is D-menthoxy, or more preferably, L-menthoxy.
10
Compounds of formulae (I) to (TX) can exist in different isomeric forms (such as cis/trans,-enantiomers, or diastereoisomers). The process of this invention includes all such isomeric forms and mixtures thereof in all proportions.
15 Where Y is chiral,' a compound of formula (I) will be a mixture of diastereoisomers and can be resolved to yield a diastereomerically-enriched compound of formula (la):
Rw ^f . (Ia)^
where R and Y are as defined above, by crystallisation or by chromatographic methods. Preferably the crystallisation is carried out in situ following the synthesis of & compound o:
20 formula (I), as described above, by heating the crude reaction mixture until total or near-tota dissolution is achieved, then cooling at an appropriate rate until sufficient crystals of the desired quality are formed. The crystals are then collected by filtration. Alternatively, the resolution can be carried out in any other suitable solvent, such as a hydrocarbon, eg heptane by extracting a compound of formula (I) into a suitable amount of the solvent, heating the
25 extracts until total dissolution is achieved, then cooling at an appropriate rate until sufficient crystals of the desired quality are formed. Optionally the organic extracts can be washed with water, dried over magnesium sulfate and filtered prior to the crystallisation described above.

• WO 01/92200

PCT/SEO1/01240

A compound of formula (la) can be hydrolysed to yield a compound of formula (Va):
A,
(Va) OH
where R is as defined above, using the method described above for the hydrolysis of a compound of formula (I) to yield a compound of formula (V).
A compound of formula (Va) can be used to generate a compound of formula (Via):

(Via) CI
where R is as defined above, using the method described above for the conversion of a
10 compound of formula (V)'to yield a compound of formula (VI).
A compound of formula (Via) can be used in the synthesis of a compound of formula (Vila):

R*

f
(Vila) ^3

15 where R is as defined above, using the method described above for the conversion of a compound of formula (VT) to yield a compound of formula (VH).
A compound of formula (Vila) can be used in the synthesis .of a compound of formula (Villa):

WO 01/92200

PCT/SEO1/01240

(VHIa)
where R is as defined above, using the method described above for the conversion of a compound of formula (VII) to yield a compound of formula (VIII).
5 A compound of formula (Villa) can be used in the synthesis of a compound of formula-(EXa):
(EXa)
where R is as defined above, using the method described above for the conversion of a
compound of formula (VIII) to 3'ield a compound of formula (IX).
10
The R-(-)-mandelic acid salt of a compound of formula (IXa) can be generated using the method described above for the generation of the mandelic acid salt of a compound of formula (IX).
15 Novel compounds form a further aspect of the invention. In a further aspect the invention
therefore provides compounds of formula (I), (la), (H),. (HI), (V), (Va), (VI), (Via), (VH),
(VIIa),.(ynr),;aana)..jaX) .and (EXa) as defined above.
. Particularly preferred compounds include:
20 (1R, 2S, 5R)-2-isopropyl-5-methylcyclohexyl -trans-2-(3,4-
difluorophenyl)cyclopropanecarboxylate;
(li2,2S,5R)-2-isopropyl-5-nethylcyclohexyl trans- (1R, 2R)-2-(3,4-
difluorophenyl)cyclopropanecarboxylate;
(1R,25,5R)-2-isopropyl-5-methylcyclohexyl(E)-3-(3,4-difluorophenyl)-2-propenoate; 25 (E)-3-(354-difluorophenyl)-2-propenoicacid;

WO 01/92200

PCT/SE0J/01240

(E)-3-(3,4-difluorophenyl)-2-propenoyl chloride;
trans-(1R, 2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid;
trans-(1R, 2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl chloride;
trans -(1R, 2R)-2-(3J4-difluorophenyl)cyclopropanecarbonyl azide;
trans -(1R,2S)-2-(3J4-difluorophenyl) cyclopropyl amine;
and trans -(1R,,2S)-(3,4-difluorophenyl)cyclopropananTinium (2R)-2-hydroxy-2-
phenylethanoate

10-

Examples
The invention is illustrated by the following non-limiting examples.

Example 1.
This example illustrates the preparation of (E)-3-(3,4-difluoropbenyl)-2-propenoic acid
15 A stirred mixture of pyridine (15.5 kg) and piperidine (0.72 kg) were heated to 90°C.
Malonic acid (17.6 kg) was added, followed by slow addition, over 50 minutes, of 3,4-
difluorobenzaldehyde (12.0 kg). .The reaction mixture was stirred at 90°C for a further 4
' hours and 36 minutes. Water (58.5 kg) was added and. 32 litres of the pyridme/water .
mixture then was distilled out of the reactor under reduced pressure. The reaction mixture
20 was acidified to pH 1 with 37% hydrochloric acid (6.4 kg) over a 40-minute period, then
cooled to 25°C with strong stirring. The-solid were-collected by filtration, washed twice
with I % hydrochloric acid (34.8 L per wash), once with water (61 L) and then deliquored thoroughly in-the filter. The product was then dried under vacuum at 40°C for 24 hours and 40 minutes, affording 13.7kg of the crystalline product
25
Example2.
This example illustrates the preparation of (5}-3-(3,4-difiuorophenyl)-2-propenoyl
chloride.

30

A stirred mixture of (E)-3-(3,4-difluorophenyl)-2-propenoic acid (8.2 kg), toluene (7.4kg) and pyridine (0.18kg) was heated to 65°C and then thionyl chloride (7.4kg) was added over 3 0 minutes. The reaction was stirred for a further 2h 15 minutes after the addition was

WO 01/92200

PCT/SE01/01240

9
complete, then diluted with toluene (8.7kg). Excess thionyl chloride, sulfur dioxide and hydrogen chloride were then distilled out, together with toluene (10 L), under reduced pressure, yielding a solution of the (E)-3-(3,4-difiuorophenyl)-2-propenoyl chloride (approximately 9 kg) in toluene.
5
Example 3.
This example illustrates the preparation of (l.R,2E,5R)-2-isopropyl-5-methylcyclohexyl (5)-3-(3)4-difluorophen}d)-2-propenoate.
10 A solution of L-menthol (7.1kg) in toluene (8.5kg) was added over a 20 minute period to
the solution of (E)-3-(3,4-difluorophenyl)-2-propenoyl chloride (prepared as in Example 2) and pyridine (0.18kg, 2.28 mol) stirring at 65°C. The reaction mixture was stirred at 65°C for a further 4 hours and 40 minutes after the addition was complete, then cooled to 25°C and stirred or a 14 hours. The solution was diluted with toluene (16kg), washed with 5% is.
15 aqueous, sodium chloride (6.4kg), then 6% sodium hydrogen carbonate (6.47kg), then water (6.1kg). The solution was dried azeotropically by distillation of the solvent (20 L) under reduced pressure'. Dimethyl sulfoxide (33.9 kg) was added and the remaining toluene was distilled off under reduced pressure, affording 47.3kg of a solution of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (E}-3-(3,4-difluorophenyl)-2-propenoate (approx. 13.3 kg)
20 in dimethyl sulfoxide.
Example 4.
This example illustrates a method of preparing dimethylsulfoxonium methylide (dimethyl(methyllene)oxo-λ6-sulfane).
25
Sodium hydroxide powder (1.2kg), prepared by milling sodium hydroxide pellets in a rotary mill through a 1mm metal sieve, and trimethylsulfoxonium iodide (62kg) were stirred in dimethyl sulfoxide (25.2kg) under a nitrogen atmosphere at 25 °C for 90 min. The • solution was used directly in the preparation of (1R, 25, 5R)-2-isopropyl-5-
30 methylcyclohexyl trans-2-(3,4-difluorophenyl) cyclopropanecarboxylate.
Example 5.

WO 01/92200

PCT/SEO1/01240

10
This example illustrates a method of preparing dimethylsulfonium methylide (dimethyl(methylene)-λ 4-sulfane).
Sodium hydroxide powder (970mg)3 prepared by milling sodium hydroxide pellets in a
5 rotary mill through a 1mm metal sieve, and trimethylsulfomum iodide (4.66 g) were stirred in dimethyl sulfoxide (17 ml) under a nitrogen atmosphere at 20-25°C for 10 rain. The solution was used directly in the preparation of (IR, IS, 5R)-2-isopropyl-5-methylcyclohexyl trans -2-(3J4-difiuorophenyl)cyclopropanecarbox}date.
10 Example-6
This example illustrates the preparation of {IR, 2S, 5R)-2-isopropyl-5-methylcyclohexyl trans -2-(3,4-difluorophenyl)cyclopropanecafboxylate
A solution of (1R,25,5R)-2-isoprppyl:5-methylcyclohexyl 3,4-difluorophenyl)-2-
15 propenoate (approximately 8.6 kg) in dimethyl sulfoxide (approximately 27.9 kg) was added with stirring over 20 minutes to a mixture of dimethylsulfoxorrium methylide . (approximately 2.6kg, prepared as described above), sodium iodide ( (^^-(approximately 4.2 kg), water (approximately 500 g) and sodium hydroxide (approximately 56 g) in dimethylsulfoxide (27.7 kg) at 25°C. The reaction-mixture was stirred for a further 2 hours
20 and 50 minutes at 25°C, then useddirectly for the preparation of (1R,2S,5R)-2-isopropyl-5- . methylcyclohexyl trans –(1R,2R)-2-(334-difiuorophenyl)cyclopropanecarboxylate.
Example 7.
This example illustrates the preparation of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 25 trans (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylate
A crude solution of (IR, 2S, 5R)-2-isoprop3d-5-methylcyclohexyl frans-2-(3,4-difluorophenyl)cyclopropanecarboxylate produced as described in example 6 was heated with stirring from 25DC to 50°C over a 1 hour period and the temperature was maintained
30 for a further hour. The mixture was then cooled with stirring from 50°C to 35°C over 4 hours, kept at 35°C for 1 hour, then cooled to-26°C over 4 hours, kept at 26°C for 1 hour,

WO 01/92200

PCT/SE01/01240

11
then cooled to 19°C over 3 hours and kept at 19°C for 5 hours and 10 minutes. The product crystallised and was collected by filtration, affording a crystalline solid (2.7 kg) which was shown to contain a mixture of (1R.2R,5R)-2-isopropyl-5-meth)4cyclohexyl trans~(1R,2R)-2-(3,4-difiuorophenyl)cyclopropanecarboxylate (1.99 kg) and (1R,2S,5R)-2-isopropyl-5-
5 methylcyclohexyl fra7iy-(l^,,2iS')-2-(3,4-difluorophenyl)cyclopropanecarboxylate (85 g).
Example 8.
This example illustrates an alternative method of preparing (17?,2iS',5.R)-2-isopropyl-5-methylcyclohexyl trans--(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylate
10
' n-Heptane (82.5 L) was distilled under reduced pressure from a solution of (IR, 25, 5R)-2-isopropyl-5-methylcyclohexyl trans-2-(3,4-difiuorophenyl)cyclopropanecarboxylate (14.3 kg, 44.4 mol) in heptane (128.6 L). The mixture was then cooled from"34°C to 24°C over a period of 3 hours and 20 minutes. Seed crystals of (1R,2S,5R)-2-isopropyl-5-
15 methylcyclohexyl trans -(1R,2R)-2-(3J4-difluorophenyl)cyclopropanecarboxylate were then added and the mixture was cooled to 0°C over a period of 5 hours and 50 minutes. Filtration afforded the product as a crystalline solvent wet solid (7.05 kg) which, was shown to contain a mixture of (1R,2S,5R)-2-isopropyl-5-meraylcyclohexyl trans-(1R,2R)- 2-(3,4-difluorophenyl)cyclopropanecarboxylate (4.7 kg) and (1R,25,5if)-2-isopropyl-5-
20 methylcyclohexyl rrare5'-(liS'325)-2-(3,4-difiuorophenyl)cyclopropanecarbox}'late (1.1 kg).
Example 9.
This example-illustrates a method of preparing trans -(1R, 2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid.,
25
(1R,25,5R)-2-isoPropyl-5-methylcyclohexyl trans-{1R,2R)-2-(3 ,4-difluorophenyl)cyclopropanecarboxylate (9.6 kg, 91.8% diastereomeric excess) was dissolved in ethanol (13.8 kg) and heated with stirring to 46°C. 45% Aqueous sodium hydroxide (3.1 kg) was added over a 20 minute period and the mixture was stirred for a 30 further 2 hours and 27 minutes. Solvent (28 L) was distilled out of the mixture under reduced pressure, then the mixture was cooled to 24° C and diluted with water (29.3 kg), after which the liberated menthol was extracted into toluene (3 washes of 3.3 kg each).

WO 01/92200 PCT/SE01/01240
12
The remaining aqueous material was acidified to pH 2 with 37% hydrochloric acid (3.3 L) and the product was extracted into toluene (8.6 kg, then 2 more washes of 4.2 kg and 4.3 kg). The combined toluene extracts were washed with 1% hydrochloric acid (4.9 L), then diluted with further toluene (4.2 kg) and azeotropically dried by distillation of the solvent
5 (25 L) under reduced pressure. A final dilution with toluene (24.2kg) was followed by distillation of the solvent under reduced pressure (10 L) affording a solution containing
trans-(1R, 2R)-2-(3,4-dMuorophenyl)cyclopropanecarboxylic acid (approximately 3.45 kg)
suitable for the production of trans -{\R, 2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl
chloride. —10—
Example 10.
This example illustrates a method of preparing trans -{1R, 2R)-2-(3,4-
difluorophenyl)cyclopropanecarbonyl chloride.
15 ' Pyridine-(70 ml) was added to a solution of trans -(1R, 2R)-2-(3,4-
difluorophenyl)cyclopropanecarboxylic acid (approximately 3.45-kg) in toluene (approximately 12 -15 kg) prepared as described above and the mixture was then heated to 65°C. Thionyl chloride (2.3kg) was added over a period of 1 hour and the mixture was stirred at 70°C for 3 hours. Thionyl chloride (0.5 kg) was added and the mixture was stirred 20 a further 2 hours at 70°C. A final aliquot of thionyl chloride (0.5 kg) was added and the reaction mixture was stirred for 1 hour at 70˚C, then cooled 40°C. Periodic additions of
toluene (45 kg, 3 additions of 15 kg each) were made during distillation of solvent (approximately 60 L) from the mixture under reduced pressure, then the solution of trans-
(1R,2R)-2-(3,4-'difluorophenyl)cyclopropanecarbonyl-cM0ride-(approximately 3.8.kg) in ...
25 toluene (approximately 6 - 9 L) was cooled to 20*C.
Example 11.
This example illustrates a method of preparing trans-(1R, 2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl azide.
A solution of trans-(1R, 2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl chloride (approximately 3.8 kg) in toluene (approximately 6 - 9 L) at 1 °C was added over a period .

WO 01/92200

PCT/SE01/01240

13
of 74 minutes to amixture of sodium azide (1.24 kg), tetrabutylammonium bromide (56 g) and sodium carbonate (922 g,) in water (6.2 kg), stirring at 1.5'C. The mixture was stirred at 0°C for 1 hour and 55 minutes, then the aqueous layer was diluted with cold water (3.8 kg), stirred briefly, then separated. The toluene layer was washed once more at 0°C with
5 water (3.8 kg), then with 20% aqueous sodium chloride (3.8 L), then stored at 3°C for further use.
Example 12.
This example illustrates a method of preparing trans-(1R,2S)-2-(3,4-
10 difluorophenyl)cyclopropylarnine.
A cold solution of trans-(1R, 2R)-2-(3,4-difiuorophenyl)cyclopropanecarbonyl azide prepared as described in Example 11 was added over a period of 41 minutes to toluene (6.0 . kg) stirring at 100°C. The mixture was stirred for a further 55 minutes at 100°C, then
15 cooled to 20°C and added over a period of 2 hours and 15 minutes to hydrochloric acid (3M, 18.2 kg) stirring at 80°C After 65 minutes the solution was diluted with water (34 kg) and cooled to 25°C The toluene layer was removed and the aqueous layer was basified to pH 12 with 45% sodium hydroxide (3.8 kg) and the product was then extracted into ethyl acetate (31 kg) and washed twice with water (13.7 kg per wash), affording a solution
20 containing trans-(1R,2S)-2-(3,4-diflorophenyl)cyclopropylamine. (2.6 kg, 91.8% enantiomeric excess) in ethyl acefate(29.5 L). ~
Example 13.
This example illustrates a method of preparing trans-(1R,2R)-2-(3,4
25 difluorophenyl)cyclopropanarninium (2E)-2-hydxoxy-2-phenylethanoate.
30
R-(-)-Mandehc acid (2.26 kg) was added to a solution containing trcms-(1R,2S)-2-{3,4-difluorophenyI)cyclopropylamine (2.6 kg, 91.8% enantiomeric excess), stirring at 17'C in ethyl acetate (45.3 L). The mixture was stirred at 25"C for 3 hours and 8 minutes, then filtered and washed twice with ethyl acetate (13.8 kg total). The crystalline product was dried at 40°C under reduced pressure for 23 hours, affording trans-{1R,2S)-2-{3,A-difluorophenyl)cyclopropanammiurn (2R)-2-hydroxy-2-phenylethanoate (4.45 kg).

WE CLAIM:
1. An intermediate compound for the preparation of compound of
formula I:



wherein: R is phenyl substituted with one or more halogen; and Y is OR1, where R1 is a straight chain alkyl, branched alkyl, cycloalkyl, or a substituted bicycloheptyl group, said compound being:
(1R, 2S, 5R)-2-isopropyl-5-methylcyclohexyl trans-2(3,4-
difluorophenyl) cyclopropanecarboxylate;
(1R, 2S, 5R)-2-isopropyl-5-methylcyclohexyl trans-(1R, 2R)-2-(3,4-difluorophenyl) cyclopropanecarboxylate; or
(1R, 2S, 5R)-2-isopropyl-5-methylcyclohexyl (E)-3-(3,4- difluorophenyl)-2-propenoate;

Dated this 21st day of September, 2006.
15-

Documents:

1124-MUMNP-2006-CANCELLED PAGES(5-5-2010).pdf

1124-MUMNP-2006-CLAIMS(AMENDED)-(5-5-2010).pdf

1124-mumnp-2006-claims(granted)-(6-6-2011).pdf

1124-mumnp-2006-claims.doc

1124-mumnp-2006-claims.pdf

1124-mumnp-2006-correspondence(14-3-2007).pdf

1124-MUMNP-2006-CORRESPONDENCE(2-5-2011).pdf

1124-MUMNP-2006-CORRESPONDENCE(22-5-2009).pdf

1124-mumnp-2006-correspondence(ipo)-(9-6-2011).pdf

1124-mumnp-2006-correspondence-received.pdf

1124-mumnp-2006-description (complete).pdf

1124-mumnp-2006-description(granted)-(6-6-2011).pdf

1124-mumnp-2006-form 13(22-5-2009).pdf

1124-mumnp-2006-form 18(16-3-2007).pdf

1124-mumnp-2006-form 2(granted)-(6-6-2011).pdf

1124-mumnp-2006-form 2(title page)-(21-9-2006).pdf

1124-mumnp-2006-form 2(title page)-(granted)-(6-6-2011).pdf

1124-mumnp-2006-form 3(21-9-2006).pdf

1124-MUMNP-2006-FORM 3(5-5-2010).pdf

1124-mumnp-2006-form 3(9-11-2006).pdf

1124-mumnp-2006-form-1.pdf

1124-mumnp-2006-form-2.pdf

1124-mumnp-2006-form-26.pdf

1124-mumnp-2006-form-3.pdf

1124-mumnp-2006-form-5.pdf

1124-MUMNP-2006-OTHER DOCUMENT(5-5-2010).pdf

1124-MUMNP-2006-PETITION UNDER RULE 137(5-5-2010).pdf

1124-MUMNP-2006-POWER OF ATTORNEY(5-5-2010).pdf

1124-MUMNP-2006-REPLY TO EXAMINATION REPORT(5-5-2010).pdf

1124-MUMNP-2006-SPECIFICATION(AMENDED)-(5-5-2010).pdf


Patent Number 247955
Indian Patent Application Number 1124/MUMNP/2006
PG Journal Number 23/2011
Publication Date 10-Jun-2011
Grant Date 06-Jun-2011
Date of Filing 21-Sep-2006
Name of Patentee ASTRAZENECA AB
Applicant Address S-151 85 Sodertalje,
Inventors:
# Inventor's Name Inventor's Address
1 ADRIAN CLARK of AstraZeneca R & D Sodertalje, S-151 85 Sodertalje,
2 ULF LARSSON of AstraZeneca R & D Sodertalje, S-151 85 Sodertalje, Sweden
3 ELFYN JONES of AstraZeneca R & D Sodertalje, S-151 85 Sodertalje, Sweden
4 ANNA MINIDIS of AstraZeneca R & D Sodertalje, S-151 85 Sodertalje, Sweden
PCT International Classification Number C07C 67/347
PCT International Application Number PCT/SE01/01240
PCT International Filing date 2001-05-31
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 0002101.4 2000-06-06 U.K.
2 0013487.4 2000-06-02 U.K.